Back to Atlas

Suki Assistant

Suki

Uses ambient listening and voice interaction to draft clinical notes and support documentation workflows.

Designed for

Clinician

Care setting

Ambulatory and hospital care

Specialty

Multispecialty

Public evidence assessedReviewed August 31, 2026

Bottom line

Suki is an established commercial documentation product, but the represented evidence base is weighted toward company and customer reports. Publicly available information supports its workflow use more clearly than its comparative clinical accuracy or long-term safety.

Based on public sources. RIR did not independently test this product. This is not an endorsement or recommendation.

What the evidence supports

Reviewed official materials establish a marketed ambient and voice documentation assistant.

What remains uncertain

Independent evidence on clinical error rates, subgroup performance, and downstream record quality remains limited in this profile.

How it was studied

Public Suki materials emphasize deployment, integration, clinician adoption, and time saved. This initial Atlas review has not yet identified a public pivotal trial that independently measures severe factual errors or patient-level outcomes for the current product version.

Intended use
Create draft clinical documentation and support voice-enabled administrative tasks for clinician review.
Represented version
Public product materials accessed August 2026; software version not specified
Regulatory context
Regulatory classification was not independently determined from the reviewed public materials.

2 public sources represented in this evidence profile.

For clinical and investment reviewEvidence context and questions for deeper review

Evidence source base

Predominantly developer and customer-reported evidence in the represented sources. Independent current-version validation is a priority gap.

Important limitation

Adoption and efficiency findings cannot establish note fidelity, rare high-severity failure rates, subgroup performance, or durability after model updates.

Questions to ask

  1. 01Which note types and specialties have independent evaluations?
  2. 02How are negation and medication errors detected?
  3. 03What audit data are available to health systems?